Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Bäckman

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Aerosol Medicine and Pulmonary Drug Delivery|October 15, 2016
Predicting Exposure After Oral Inhalation of the Selective Glucocorticoid Receptor Modulator, AZD5423, Based on Dose, Deposition Pattern, and Mechanistic Modeling of Pulmonary DispositionPer Bäckman, Ulrika Tehler, Bo Olsson
Drug Design, Development and Therapy|November 3, 2025
Relative Bioavailability of Inhaled Fluticasone Propionate and Salmeterol - is Population Pharmacokinetic Modelling a Relevant Alternative to a Non-Compartmental Approach?Johan Rosenborg, Per Bäckman, Thomas Bengtsson, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 2, 2017
Pulmonary absorption - estimation of effective pulmonary permeability and tissue retention of ten drugs using an ex vivo rat model and computational analysisJohanna Eriksson, Erik Sjögren, Helena Thörn, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 29, 2017
Advances in experimental and mechanistic computational models to understand pulmonary exposure to inhaled drugsPer Bäckman, Sumit Arora, William Couet, et al.
The AAPS Journal|May 6, 2015
In Vitro Testing for Orally Inhaled Products: Developments in Science-Based Regulatory ApproachesBen Forbes, Per Bäckman, David Christopher, et al.
Molecular Pharmaceutics|October 10, 2018
Ranking in Vitro Dissolution of Inhaled Micronized Drug Powders including a Candidate Drug with Two Different Particle SizesFrans Franek, Rebecca Fransson, Helena Thörn, et al.
American Journal of Respiratory Cell and Molecular Biology|November 3, 2015
A Proposed In Vitro Method to Assess Effects of Inhaled Particles on Lung Surfactant FunctionJorid B Sørli, Emilie Da Silva, Per Bäckman, et al.
The AAPS Journal|March 11, 2017
Pharmacokinetics of the Inhaled Selective Glucocorticoid Receptor Modulator AZD5423 Following Inhalation Using Different DevicesJohanna Melin, Susanne Prothon, Charlotte Kloft, et al.
Pharmacological Reviews|January 6, 2022
Inhaled Medicines: Past, Present, and FutureSandra Anderson, Paul Atkins, Per Bäckman, et al.
Journal of Pharmaceutical Sciences|April 19, 2017
Current Progress Toward a Better Understanding of Drug Disposition Within the Lungs: Summary Proceedings of the First Workshop on Drug Transporters in the LungsCarsten Ehrhardt, Per Bäckman, William Couet, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Aerosol Medicine and Pulmonary Drug Delivery|October 15, 2016
Predicting Exposure After Oral Inhalation of the Selective Glucocorticoid Receptor Modulator, AZD5423, Based on Dose, Deposition Pattern, and Mechanistic Modeling of Pulmonary DispositionPer Bäckman, Ulrika Tehler, Bo Olsson
Drug Design, Development and Therapy|November 3, 2025
Relative Bioavailability of Inhaled Fluticasone Propionate and Salmeterol - is Population Pharmacokinetic Modelling a Relevant Alternative to a Non-Compartmental Approach?Johan Rosenborg, Per Bäckman, Thomas Bengtsson, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 2, 2017
Pulmonary absorption - estimation of effective pulmonary permeability and tissue retention of ten drugs using an ex vivo rat model and computational analysisJohanna Eriksson, Erik Sjögren, Helena Thörn, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 29, 2017
Advances in experimental and mechanistic computational models to understand pulmonary exposure to inhaled drugsPer Bäckman, Sumit Arora, William Couet, et al.
The AAPS Journal|May 6, 2015
In Vitro Testing for Orally Inhaled Products: Developments in Science-Based Regulatory ApproachesBen Forbes, Per Bäckman, David Christopher, et al.
Molecular Pharmaceutics|October 10, 2018
Ranking in Vitro Dissolution of Inhaled Micronized Drug Powders including a Candidate Drug with Two Different Particle SizesFrans Franek, Rebecca Fransson, Helena Thörn, et al.
American Journal of Respiratory Cell and Molecular Biology|November 3, 2015
A Proposed In Vitro Method to Assess Effects of Inhaled Particles on Lung Surfactant FunctionJorid B Sørli, Emilie Da Silva, Per Bäckman, et al.
The AAPS Journal|March 11, 2017
Pharmacokinetics of the Inhaled Selective Glucocorticoid Receptor Modulator AZD5423 Following Inhalation Using Different DevicesJohanna Melin, Susanne Prothon, Charlotte Kloft, et al.
Pharmacological Reviews|January 6, 2022
Inhaled Medicines: Past, Present, and FutureSandra Anderson, Paul Atkins, Per Bäckman, et al.
Journal of Pharmaceutical Sciences|April 19, 2017
Current Progress Toward a Better Understanding of Drug Disposition Within the Lungs: Summary Proceedings of the First Workshop on Drug Transporters in the LungsCarsten Ehrhardt, Per Bäckman, William Couet, et al.
Pageof 2